Drug Development
Page 1 • 4 itemsGain critical insights into global drug development trends, clinical trial advancements, regulatory hurdles, and R&D strategies for pharma investors and BD.
Aquestive Therapeutics Faces Class Action Lawsuit Over Anaphylm Drug Approval Timeline Claims
Investors file class action against Aquestive Therapeutics alleging misleading statements about Anaphylm sublingual film approval timeline and January 2026 PDUFA date.
NOVI Health's Hybrid Care Model Bridges GLP-1 Drug Efficacy Gap Between Clinical Trials and Real-World Outcomes
NOVI Health introduces hybrid care approach to improve real-world GLP-1 obesity drug outcomes that typically underperform compared to clinical trials.
SynSmart and Amporin Partner to Develop Small Molecule Therapeutics for Degenerative Diseases
SynSmart Rasayan Research and Amporin Pharmaceuticals announce collaboration to develop breakthrough small molecule treatments for fatal degenerative diseases.
Antengene Presents Next-Generation ADC and AnTenGager TCE Programs at AACR 2026
Antengene showcases three novel oncology programs at AACR 2026, featuring next-generation ADC technology and AnTenGager T-cell engagers for cancer treatment.